We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Researchers Develop Chip for Biomolecule Detection to Aid COVID-19 Testing

By LabMedica International staff writers
Posted on 03 Jun 2020
Print article
Image: Researchers Develop Chip for Biomolecule Detection to Aid COVID-19 Testing (Photo courtesy of Purdue University)
Image: Researchers Develop Chip for Biomolecule Detection to Aid COVID-19 Testing (Photo courtesy of Purdue University)
Researchers have developed a patented method for single biomolecule detection that overcomes limitations of current technologies and could help in the fight against COVID-19.

Purdue University (West Lafayette, Ind., USA) innovators have created a method that uses a special sensor similar to a computer chip. The application-specific integrated circuit chip is designed for the early detection of a number of pathogens and viruses. The technique involves machine learning to train the system to detect certain features associated with particular diseases and viruses. Then, when a sample is run through the system, it can detect those features and confirm the presence of particular viruses and diseases. Simulations have shown this technique could be effective in detecting COVID-19.

The method uses a metal-oxide semiconductor sensor with embedded, fluidic nanochannels. As a biomolecule moves through the nanochannel, a high frequency current is measured that contains information about the biomolecule, such as the type of nucleotides in the case of DNA/RNA, which can be used to classify the molecule.

“This method does not have the problems associated with other nanopore techniques because it does not require the difficult drilling of extremely small nanopores, can detect four nucleotides at a time, and is not significantly affected by the rotation or position of the biomolecule in the nanochannel,” said Saeed Mohammadi, a Purdue professor of electrical and computer engineering. “We want to find partners to move this technology to the public as soon as we can to help in COVID-19 testing. We know it can be an effective, easy and inexpensive method for detecting viruses, potentially the one linked to the current pandemic.”

Related Links:
Purdue University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.